Analytical sensitivity analysis and clinical impact modeling of Rapigen rapid diagnostics tests for malaria
Authors:
Preprint
Abstract
Analytical performance analysis through laboratory benchmarking can more objectively compare the performance of malaria rapid diagnostic tests (RDTs). We present the analytical detection limits of the Rapigen BIOCREDIT Malaria Ag Pf/Pv (pLDH/pLDH), the Rapigen BIOCREDIT Malaria Ag Pf (pLDH/HRPII), and two best-in-class World Health Organization (WHO)-prequalified comparator RDTs, generated using standardized panels containing recombinant antigen, in vitro cultured parasites, international standards, and clinical samples. Detection limits of HRP2, PfLDH, and PvLDH were determined for the Rapigen and comparator RDTs as antigen concentration and in international units (IU)/mL. The Rapigen Ag Pf (pLDH/HRPII) detected 3.9 and 3.9 IU/mL for PfLDH and HRP2, respectively, while the Ag Pf/Pv (pLDH/pLDH) detected 3.9 and 5.0 IU/mL for PfLDH and PvLDH, respectively. The comparator HRP2/PfLDH and HRP2/PvLDH detected 15.6 and 31.3 IU/mL for HRP2 and PfLDH and 15.6 and 50.0 IU/mL for HRP2 and PvLDH, respectively. The RDT clinical sensitivity was predicted through application of analytical detection limits to antigen concentration distributions from clinical symptomatic and asymptomatic cases. Febrile cases would be detected in majority by both standard and Rapigen RDTs, though with increases in the Rapigen RDTs that may be important for clinical cases currently missed by microscopy. Rapigen RDTs were predicted to increase the detection of asymptomatic cases and improve the detection of hrp2 deletions through PfLDH detection. Through the benchmarking and simulation of clinical sensitivity, a method for rapidly assessing the ability of new RTDs to meet clinical needs using high-sensitivity antigen distribution data is presented.Keywords
All Related Versions
- Published version: The American Journal of Tropical Medicine and Hygiene, 111 (5), 956.
This publication has 22 references indexed in Scilit:
- Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge InfectionsThe American Journal of Tropical Medicine and Hygiene, 2017
- Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profilesPLOS Neglected Tropical Diseases, 2017
- brms: An R Package for Bayesian Multilevel Models Using Stan2017
- Alternative methods for the Plasmodium falciparum artemisinin ring-stage survival assay with increased simplicity and parasite stage-specificityMalaria Journal, 2016
- Combining Parasite Lactate Dehydrogenase-Based and Histidine-Rich Protein 2-Based Rapid Tests To Improve Specificity for Diagnosis of Malaria Due to Plasmodium knowlesi and Other Plasmodium Species in Sabah, MalaysiaJournal of Clinical Microbiology, 2014
- Evaluation of the Sensitivity of a pLDH-Based and an Aldolase-Based Rapid Diagnostic Test for Diagnosis of Uncomplicated and Severe Malaria Caused by PCR-Confirmed Plasmodium knowlesi, Plasmodium falciparum, and Plasmodium vivaxJournal of Clinical Microbiology, 2013
- Molecular Diagnosis of Malaria by Photo-Induced Electron Transfer Fluorogenic Primers: PET-PCRPLOS ONE, 2013
- Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytesProceedings of the National Academy of Sciences, 2012
- Cross-reactivity in rapid diagnostic tests between human malaria and zoonotic simian malaria parasite Plasmodium knowlesi infectionsParasitology International, 2009
- Human Malaria Parasites in Continuous CultureScience, 1976